Standing Ovation raises €30 million to scale precision fermentation dairy proteins globally

Europe’s precision fermentation sector is entering a decisive phase of commercialisation, as investors and food industry incumbents increasingly back technologies that promise to decouple protein production from animal agriculture. The global precision fermentation market, valued at approximately $3 billion in Europe alone, is projected to grow at a compound annual rate exceeding 38 per cent through the end of the decade, driven by regulatory support, climate commitments, and shifting consumer demand for sustainable food systems.

Paris-based Standing Ovation has secured €30 million ($34.2 million) in Series B financing to accelerate the commercialisation of its precision fermentation technology, which produces dairy-identical casein proteins without the use of animals. The round comprises €25 million in equity, jointly led by the Ecotechnologies 2 fund managed by Bpifrance as part of the France 2030 programme and Crédit Mutuel Innovation, supplemented by €5 million in non-dilutive financing from Bpifrance and a banking syndicate. The investment brings Standing Ovation’s total funding to approximately €46 million.

Strategic investors signal industrial confidence in alternative proteins

The investor syndicate reflects a deliberate convergence of public funding, strategic food industry capital, and impact-oriented venture investors. Existing shareholders Astanor, Bel Group, Seventure Partners, GoodStartUp, and Big Idea Ventures were joined by new investors including Danone Ventures, Angelor, Newtree Impact, and Noshaq.

The participation of both Bel Group and Danone Ventures is particularly significant, representing two major European dairy corporations placing strategic bets on precision fermentation as a core component of their future ingredient supply chains. This dual endorsement from industry incumbents suggests that precision-fermented proteins are transitioning from experimental alternative to credible industrial input.

“We are bridging the gap between the agri-food industry and deep tech,” the company’s leadership stated, highlighting their circular approach to protein production that converts whey permeates and agricultural sugars into high-quality casein through proprietary fermentation processes.

Standing Ovation’s flagship ingredient, Advanced Casein, is produced through a process that the company claims generates 74 per cent lower greenhouse gas emissions and requires three times less water than conventional animal-derived casein. The technology is protected by eight patent families, and the company holds the French Tech 2030 designation, signalling government recognition of its strategic importance to national food sovereignty.

European precision fermentation market gathers pace

The timing of Standing Ovation’s raise coincides with accelerating momentum across Europe’s precision fermentation landscape. Germany, the United Kingdom, and France are emerging as the continent’s leading centres for fermentation-derived protein production, supported by public funding programmes and a growing network of contract manufacturing partnerships.

Founded in 2020 by microbiologist and agronomist Romain Chayot, Standing Ovation now employs 36 people and is led by CEO Yvan Chardonnels, a specialist in B2B strategic transformation. The company plans to use the new capital to launch commercial operations in the United States in 2026, followed by expansion into European and Asian markets from the end of 2027. Manufacturing will be scaled through partner facilities rather than proprietary production plants, a capital-efficient approach that several European biotech companies have adopted to accelerate time to market.

The broader context for this investment is the global protein demand challenge. An estimated 250 million additional metric tonnes of protein will be required by 2050 to feed the world’s growing population, a gap that conventional animal agriculture alone cannot sustainably fill. Standing Ovation’s approach positions precision fermentation as a sovereign, European-manufactured response to this challenge, reducing dependence on imported animal feed and volatile agricultural supply chains.

With its Series B complete, Standing Ovation joins a growing cohort of European precision fermentation companies progressing from laboratory validation to industrial-scale production, marking a pivotal shift in how the continent approaches food security and climate-aligned agriculture.